$CREX

Creative Realities Inc expected to post a loss of 46 cents a share - Earnings Preview

Creative Realities Inc (CREX) is projected to report a loss of 46 cents per share, according to an earnings preview. This information is provided by Refinitiv. The article focuses solely on this financial forecast.

Original reporting
TradingView · Refinitiv
Published May 14, 2026, 2:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 14, 2026, 3:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CREX
Bearish
high confidence
Mentioned
$CREX
alphai data visualization · based on TradingView
Decision brief

The 30-second read

$CREXBearishMed
01

Why it matters

The anticipated loss may pressure the stock, but sector-wide trends and company-specific developments should be monitored for a comprehensive view.

02

Market read

While CREX's earnings outlook is negative, the company's small size and sector mean the impact on broader markets is limited.

03

What to watch

Potential for short-term oversold conditions leading to a bounce; upcoming sector catalysts or macroeconomic factors could influence stock movement.

Timing: short-term (next 1-2 weeks)

Background

Creative Realities Inc operates in the digital media and advertising sector, which has been volatile amid macroeconomic uncertainties.

Company-level read

Ticker impact

$CREXBearishHigh confidence
Context

Primary focus of the news due to earnings forecast.

Expected impact

Moderate decline in stock price post-earnings report, approximately 10-15%.

Evidence & confidence

The earnings forecast is based on a reputable source (Refinitiv) and reflects a clear financial expectation. The bearish sentiment is reinforced by the negative analyst consensus and the stock's current bearish sentiment score (-0.37). Technical indicators and recent trading volume should be reviewed for confirmation.

Market effects

The digital media and advertising sector may experience slight negative sentiment due to CREX's expected loss, but the impact is limited given the company's small market cap.

Minimal regional impact; the news pertains primarily to a U.S.-based company.

Negligible; the company's size and sector limit global market influence.

Counterpoint

The market may have already priced in the expected loss, and any positive surprise or better-than-expected guidance could lead to a quick rebound.

Key entities

  • Creative Realities Inc

    A digital media and advertising company focused on innovative digital solutions.

Related articles

$CREXMed

Creative Realities, Inc. Q2 2026 Earnings Call Summary

Creative Realities, Inc. reported Q2 2026 revenue of $21.5M, up 65% YoY, driven by CDM integration and new legacy installations. It said it has realized about 75% of $10M targeted annualized synergies. Net loss more than doubled. The company raised $12M via equity, expects record Q3 revenue and higher ARR from Jan 2027, and margin recovery in 2027.

$CREXMed

CREATIVE REALITIES, INC. (CREX): Results of Operations and Financial Condition

CREATIVE REALITIES, INC. (CREX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Creative Realities Reports Fiscal 2026 Second Quarter Results Record Second Quarter Revenue and Improved Outlook as Company Continues Transformation LOUISVILLE, KY – August 13, 2026 – Creative Realities, Inc. (“Creative Realities,” “CRI,” or the

$CREXMedAI 8/10

Creative Realities Announces Pricing of $12 Million Public Offering

Creative Realities, Inc. priced an underwritten public offering of 2,528,571 shares at $3.50 per share and pre-funded warrants for up to 900,000 shares at $3.49 per warrant (plus a $0.01 exercise price). Gross proceeds are expected at about $12.0M. A 30-day option allows the underwriter to buy 428,614 additional shares. Net proceeds will fund working capital, corporate uses, debt paydown, and potential acquisitions; closing expected around June 30, 2026.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.